About

Learn more about our mission and team.

Mission

Our mission is to transform the standard of care for hypertrophic cardiomyopathy and related conditions.

[data-wf-bgvideo-fallback-img] { display: none; } @media (prefers-reduced-motion: reduce) { [data-wf-bgvideo-fallback-img] { position: absolute; z-index: -100; display: inline-block; height: 100%; width: 100%; object-fit: cover; } }

About Us

Braveheart’s team represents an accomplished, mission-driven group of people committed to advancing care for patients.

Leadership

Travis Murdoch, M.D.

Chief Executive Officer and Board Director

Michele Anderson

Chief Development Officer

Tyler Chavez, Ph.D.

Chief Business Officer

Emil deGoma, M.D.

Chief Medical Officer

Marc Evanchik, M.S.

Chief Scientific Officer

Chief Financial Officer

Carlos L. del Rio, Ph.D.

Senior Vice President, Cardiovascular Research & Translational Science

Senior Vice President, Chemistry, Manufacturing & Controls (CMC)

Brittany de Temple

Senior Vice President, Development Operations

Board of Directors

Chris Viehbacher

Chair of the Board

Vineeta Agarwala, M.D., Ph.D.

Board Director

Jasper Bos, Ph.D.

Board Director

Erez Chimovits, M.B.A., M.Sc.

Board Director

Tim Lohoff, Ph.D.

Board Director

David Lubner

Board Director

David Malek, M.B.A.

Board Director

[data-wf-bgvideo-fallback-img] { display: none; } @media (prefers-reduced-motion: reduce) { [data-wf-bgvideo-fallback-img] { position: absolute; z-index: -100; display: inline-block; height: 100%; width: 100%; object-fit: cover; } }

Interested in joining our team?

Learn more about our openings.